Feasibility of a standard cognitive assessment in European academic memory clinics.
暂无分享,去创建一个
S. Cappa | A. Monsch | B. Winblad | K. Welsh-Bohmer | S. Teipel | L. Frölich | D. Altomare | M. Boccardi | S. Gauthier | L. Preis | Alice Grazia
[1] A. O’Cathain,et al. Adapting interventions to new contexts—the ADAPT guidance , 2021, BMJ.
[2] Kwun Chuen Gary Chan,et al. Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[3] B. Dubois,et al. Biomarker counseling, disclosure of diagnosis and follow‐up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey , 2020, International journal of geriatric psychiatry.
[4] H. Hampel,et al. Biomarkers for Alzheimer’s Disease (AD) and the Application of Precision Medicine , 2020, Journal of personalized medicine.
[5] F. Molnar,et al. One Size Does Not Fit All: Choosing Practical Cognitive Screening Tools for Your Practice , 2020, Journal of the American Geriatrics Society.
[6] Rachel C. Shelton,et al. Advancing health equity through CTSA programs: Opportunities for interaction between health equity, dissemination and implementation, and translational science , 2020, Journal of Clinical and Translational Science.
[7] Kwun Chuen Gary Chan,et al. Differentiating among stages of cognitive impairment in aging: Version 3 of the Uniform Data Set (UDS) neuropsychological test battery and MoCA index scores , 2020, Alzheimer's & dementia.
[8] B. Dubois,et al. Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) supported by Emerging Digital Technologies , 2019, The Journal of Prevention of Alzheimer's Disease.
[9] Kai Wang,et al. Consensus statement on the neurocognitive outcomes for early detection of mild cognitive impairment and Alzheimer dementia from the Chinese Neuropsychological Normative (CN-NORM) Project , 2019, Journal of global health.
[10] R. Harwood,et al. PROTOCOL FOR THE PROCESS EVALUATION OF THE PROMOTING ACTIVITY, INDEPENDENCE AND STABILITY IN EARLY DEMENTIA AND MILD COGNITIVE IMPAIRMENT (PRAISED 2) RANDOMISED CONTROLLED TRIAL , 2019, Alzheimer's & Dementia.
[11] S. Teipel,et al. A Tablet App– and Sensor-Based Assistive Technology Intervention for Informal Caregivers to Manage the Challenging Behavior of People With Dementia (the insideDEM Study): Protocol for a Feasibility Study , 2018, JMIR research protocols.
[12] G. Mountain,et al. Alzheimer Europe's position on involving people with dementia in research through PPI (patient and public involvement) , 2018, Aging & mental health.
[13] V. Mor,et al. Identifying and Supporting Nonpharmacological Dementia Interventions Ready for Pragmatic Trials: Results From an Expert Workshop. , 2018, Journal of the American Medical Directors Association.
[14] J. Clarimón,et al. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.
[15] Fernán Gonzalez Bernaldo de Quirós,et al. Change Management Strategies: Transforming a Difficult Implementation into a Successful One , 2017, MedInfo.
[16] T. Kan,et al. Use and implementation of standard operating procedures and checklists in prehospital emergency medicine: a literature review. , 2016, The American journal of emergency medicine.
[17] A. Fagan,et al. Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research , 2015, Alzheimer's & Dementia.
[18] A. O’Cathain,et al. Process evaluation of complex interventions: Medical Research Council guidance , 2015, BMJ : British Medical Journal.
[19] David R. Roalf,et al. Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging , 2013, Alzheimer's & Dementia.
[20] J. Becker,et al. Normative data of a brief neuropsychological battery for Spanish individuals older than 49 , 2012, Journal of clinical and experimental neuropsychology.
[21] A. Monsch,et al. Comparison of verbal episodic memory measures: Consortium to establish a registry for Alzheimer's disease - neuropsychological assessment battery (CERAD-NAB) vs. California verbal learning test (CVLT) , 2011, Alzheimer's & Dementia.
[22] Ruth E Nieuwenhuis-Mark,et al. The Death Knoll for the MMSE: Has It Outlived Its Purpose? , 2010, Journal of geriatric psychiatry and neurology.
[23] J. Mackenbach,et al. Class-related health inequalities are not larger in the East: a comparison of four European regions using the new European socioeconomic classification , 2008, Journal of Epidemiology & Community Health.
[24] B. Vellas,et al. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey , 2005, International journal of geriatric psychiatry.
[25] A. Monsch,et al. Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease. , 2000, Studies in health technology and informatics.
[26] R. Nickerson. Confirmation Bias: A Ubiquitous Phenomenon in Many Guises , 1998 .